Skip to main content

Advertisement

Log in

A Randomized Trial Comparing the Efficacy of Methylene Blue Dye Alone Versus Combination of Methylene Blue Dye and Radioactive Sulfur Colloid in Sentinel Lymph Node Biopsy for Early Stage Breast Cancer Patients

  • Original Article
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

Abstract

Although sentinel lymph node biopsy (SLNB) has become a standard of care for management of axilla in breast cancer patients, the technique of SLNB is still not well defined. Unlike radioactive sulfur colloid which requires nuclear medicine facilities, methylene blue dye is readily available. The purpose of this study is to validate the use of methylene blue dye alone for SLNB in early breast cancer patients. 60 patients of early breast cancer were randomized to receive either methylene blue alone (Group A-30 patients) or a combination of both methylene blue and radioactive colloid (Group B-30 patients) for detection of sentinel lymph nodes. Sentinel lymph node biopsy was done followed by complete axillary dissection in all patients. In both Groups A and B, sentinel node was identified in all 30 patients, giving identification rate of 100%. In group A, sentinel node was the only positive node in 1 patient, with a false-positive rate of 14.2%. The negative predictive value was 91.3%. The sensitivity of the procedure in predicting further axillary disease was 75% with a specificity of 95.45%. The overall accuracy was 90%. In group B, sentinel node was the only positive node in 2 cases, giving a false-positive rate of 28.7%. The negative predictive value was 95.65%. The sensitivity of the procedure in predicting further axillary disease was 83.33% with a specificity of 91.67%. The overall accuracy was 90%. Although the false-negative rate was slightly higher with methylene blue alone than that using combination (8.6%–4.3%), it was statistically insignificant. Similarly the sensitivity (75%–83.33%), specificity (95.45–91.67%), and negative predictive value (91.3%–95.67%) were also comparable between groups A and B, respectively. Negative predictive value and false-negative rates are comparable, whether blue dye is used alone or a combination of blue dye and radioactive colloid is used. Sentinel lymph node biopsy with blue dye alone is reliable and can be put to clinical practice more widely, even if nuclear medicine facilities are not available in resource constrained centers, so as to reduce long-term morbidity of axillary dissection, with similar oncological outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Cady B (1984) Lymph node metastases. Indicators, but not governors of survival. Arch Surg 119:1067–1072

    Article  CAS  PubMed  Google Scholar 

  2. Cuschieri A, Weeden S, Fielding J et al (1999) Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Br J Cancer 79:1522–1530

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I, Welvaart K, van Krieken J, Meijer S, Plukker JT, van Elk P, Obertop H, Gouma DJ, van Lanschot J, Taat CW, de Graaf PW, von Meyenfeldt M, Tilanus H, Sasako M (2004) Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 22:2069–2077

    Article  CAS  PubMed  Google Scholar 

  4. Pezim ME, Nicholls RJ (1984) Survival after high or low ligation of the inferior mesenteric artery during curative surgery for rectal cancer. Ann Surg 200:729–733

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Slingluff CL Jr, Stidham KR, Ricci WM et al (1994) Surgical management of regional lymph nodes in patients with melanoma. Experience with 4682 patients. Ann Surg 219:120–130

    Article  PubMed  PubMed Central  Google Scholar 

  6. Weisenburger TH 1994 Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. LCSG 773 . Chest;106:297–301

    CAS  PubMed  Google Scholar 

  7. Gervasoni JE Jr, Sbayi S, Cady B (2007) Role of lymphadenectomy in surgical treatment of solid tumors: an update on the clinical data. Ann Surg Oncol 14:2443–2462

    Article  PubMed  Google Scholar 

  8. Lucci A Jr, Kelemen PR, Miller C III et al (2001) National practice patterns of sentinel lymph node dissection for breast carcinoma. J Am Coll Surg 192:453–458

    Article  PubMed  Google Scholar 

  9. Asselius G (1627) De lactibus sine ladeis venis. Milan, Medilanis, apud lob Bidellium

    Google Scholar 

  10. Baiba J. Grube and Armando E. Giuliano (2009) Breast. Comprehensive management of benign and malignant diseases. 4th ed. Philadelphia: Elsevier Health Sciences ,: Chapter 55. Lymphatic Mapping and Sentinel Lymphadenectomy for Breast Cancer ;971–1006

  11. Radovanovic Z, Golubovic A, Plzak A, Stojiljkovic B, Radovanovic D (2004) Blue dye versus combined blue dye radioactive tracer technique in detection of sentinel lymph node in breast cancer. Eur J Surg Oncol 30(9):913–917

    Article  CAS  PubMed  Google Scholar 

  12. Mainiero MB, Cinelli CM, Koelliker SL, Graves TA, Chung MA (2010) Axillary ultrasound and fine-needle aspiration in the preoperative evaluation of the breast cancer patient: an algorithm based on tumor size and lymph node appearance. AJR Am J Roentgenol 195(5):1261–1267

    Article  PubMed  Google Scholar 

  13. Albertini JJ, Lyman GH, Cox C et al (1996) Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276:1818–1822

    Article  CAS  PubMed  Google Scholar 

  14. Mariani G, Villa G, Gipponi M et al (2000) Mapping sentinel lymph node in breast cancer by combined lymphoscintigraphy, blue dye, and intraoperative gamma-probe. Cancer Biother Radiopharm 15:245–252

    Article  CAS  PubMed  Google Scholar 

  15. Doting M, Jansen L, Niewig O et al (2000) Lymphatic mapping with intralesional tracer administration in breast carcinoma patients. Cancer 88:2546–2552

    Article  CAS  PubMed  Google Scholar 

  16. Imoto S, Hasebe T (1999) Initial experience with sentinel node biopsy in breast cancer at the National Cancer Center Hospital East. Jpn J Clin Oncol 29:11–15

    Article  CAS  PubMed  Google Scholar 

  17. McMasters KM, Tuttle TM, Carlson DJ, Brown CM, Noyes RD, Glaser RL, Vennekotter DJ et al (2000) Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 18(13):2560–2566

    Article  CAS  PubMed  Google Scholar 

  18. Motomura K, Inaji H, Komoike Y et al (2001) Combination technique is superior to dye alone in identification of the sentinel node in breast cancer patients. J Surg Oncol 76, 95:–99

    Article  CAS  PubMed  Google Scholar 

  19. Frisell J, Bergqvist L, Liljegren G et al (2001) Sentinel node in breast cancer—a Swedish pilot study of 75 patients. Eur J Surg 167:179–183

    Article  CAS  PubMed  Google Scholar 

  20. Tafra L, Lannin DR, Swanson MS et al (2001) Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue. Ann Surg 233:51–59

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Krag DN, Anderson SJ, Julian TB et al (2007) Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: Results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8:881–888

    Article  CAS  PubMed  Google Scholar 

  22. Veronesi U, Paganelli G, Galimberti V et al (1997) Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349:1864–1867

    Article  CAS  PubMed  Google Scholar 

  23. Eldrageely K, Vargas MP, Khalkhali I et al (2004) Sentinel lymph node mapping of breast cancer: a case-control study of methylene blue tracer compared to isosulfan. Am Surg 70:872–875

    PubMed  Google Scholar 

  24. Blessing W, Stolier A, Teng S et al (2002) Comparison of methylene blue and isosulfan blue dyes for sentinel node mapping in breast cancer: a trial born out of necessity. Am J Surg 184:341–345

    Article  PubMed  Google Scholar 

  25. Varghese P, Mostafa A, AbdelRahman AT, Akberali S, Gattuso J, Canizales A, Wells CA, Carpenter R (2007) Methylene blue dye versus combined dye radioactive tracer technique for sentinel lymph node localisation in early breast. Eur J Surg Oncol 33(2):147–152

    Article  CAS  PubMed  Google Scholar 

  26. Morgan A, Howisey R, Aldape H et al (1999) Initial experience in a community hospital with sentinel lymph node mapping and biopsy for evaluation of axillary lymph node status in palpable invasive breast cancer. J Surg Oncol 72:24–31

    Article  CAS  PubMed  Google Scholar 

  27. Smillie T, Hayashi A, Rusnak C et al (2001) Evaluation of feasibility and accuracy of sentinel node biopsy in early breast cancer. Am J Surg 181:427–443

    Article  CAS  PubMed  Google Scholar 

  28. Cote R, Giuliano AE, Hawes D, Ballman KV, Whitworth PW, Blumencranz PW et al (2010) ACOSOG Z0010: a multicenter prognostic study of sentinel node (SN) and bone marrow (BM) micrometastases in women with clinical T1/T2 N0 M0 breast cancer. J Clin Oncol 28(Suppl. 18):CRA504

    Article  Google Scholar 

  29. Morrow M, Rademaker AW, Bethke KP et al (1999) Learning sentinel node biopsy: Results of a prospective randomized trial of two techniques. Surgery 126:714–720

    Article  CAS  PubMed  Google Scholar 

  30. Cserni G, Rajtar M, Boross G, Sinko M, Svebis M, Baltas B (2002) Comparison of vital Dye guided lymphatic mapping and dye plus gamma probe guided sentinel node biopsy in breast cancer. World J Surg 26:592–597

    Article  PubMed  Google Scholar 

  31. Cavanese G, Gipponi M, Catturich A et al (2000) Sentinel lymph nodemapping in early-stage breast cancer: technical issues and results withvital blue dye mapping and radio-guided surgery. J Surg Oncol 74:61–68

    Article  Google Scholar 

  32. Klauber-DeMore N, Bevilacqua JL, Van Zee KJ, Borgen P, Cody HS (2001) Comprehensive review of the management of internal mammary lymph node metastases in breast cancer. J Am Coll Surg 193:547–555

    Article  CAS  PubMed  Google Scholar 

  33. Chen RC, Lin NU, Golshan M, Harris JR, Bellon JR (2008) Internal mammary nodes in breast cancer: diagnosis and implications for patient management—a systematic review. J Clin Oncol 26:4981–4989

    Article  PubMed  Google Scholar 

  34. Dome’nech-Vilardell A, Baje’n MT, Benítez AM, Ricart Y, Mora J, Rodríguez-Bel L et al (2009) Removal of the internal mammary sentinel node in breast cancer. Nucl Med Commun 30:962–970

    Article  Google Scholar 

  35. Sun X, Liu JJ, Wang YS, Wang L, Yang GR, Zhou ZB, Li YQ, Liu YB, Li TY (2010) Roles of preoperative lymphoscintigraphy for sentinel lymph node biopsy in breast cancer patients. Jpn J Clin Oncol 40(8):722–725

    Article  PubMed  Google Scholar 

  36. Burak WE Jr, Walker MJ, Yee LD, Kim JA, Saha S, Hinkle G et al (1999) Routine preoperative lymphoscintigraphy is not necessary prior to sentinel node biopsy for breast cancer. Am J Surg 177:445–9. 11

    Article  PubMed  Google Scholar 

  37. McMasters KM, Wong SL, Tuttle TM, Carlson DJ, Brown CM, Dirk Noyes R et al (2000) Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes. Ann Surg 231:724–31. 12

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Cox CE, Haddad F, Bass S, Cox JM, Ku N, Berman C et al (1998) Lymphatic mapping in the treatment of breast cancer. Oncology 12:1283–1298

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vikas Gupta.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gupta, V., Raju, K., Rao, T.S. et al. A Randomized Trial Comparing the Efficacy of Methylene Blue Dye Alone Versus Combination of Methylene Blue Dye and Radioactive Sulfur Colloid in Sentinel Lymph Node Biopsy for Early Stage Breast Cancer Patients. Indian J Surg Oncol 11, 216–222 (2020). https://doi.org/10.1007/s13193-019-01023-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-019-01023-3

Keywords

Navigation